ESC 365 - Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device

EHRA Premium Access

Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device

Session: Atrial fibrillation: clinical

Topic: Treatment

Speaker: Assistant Professor T. Nantsupawat (Chiang Mai, TH)

Event: EHRA 2024

Congress Presentation

About the speaker

Assistant Professor Teerapat Nantsupawat

Chiang Mai University, Chiang Mai (Thailand)

0 follower

7 more presentations in this session

Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study

Speaker: Doctor J. Hytting (Norrkoping, SE)

Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke

Speaker: Professor A. Jadidi (Luzern, CH)

Incidence and outcome of periinterventional atrial fibrillation in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Speaker: Mr J. Jost (Vienna, AT)

Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

Speaker: Doctor B. Corica (Modena, IT)

Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial

Speaker: Doctor L. Xing (Copenhagen, DK)

Access the full session

Atrial fibrillation: clinical

Speakers: Assistant Professor T. Nantsupawat, Doctor J. Hytting, Professor A. Jadidi, Mr J. Jost, Doctor B. Corica...

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources